Cerenome secures up to $20 million facility to scale CNSide diagnostics

Verifying
  • Cerenome entered a financing agreement with 3i, LP, for a senior secured facility.
  • The facility provides up to $20 million through initial and milestone-linked future tranches.
  • Cerenome forecasts its cash runway will extend well into 2028.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.